Stock CTMX CYTOMX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions CytomX Therapeutics, Inc.

Equities

CTMX

US23284F1057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-17 pm EDT 		5-day change 1st Jan Change
1.37 USD -0.72% Intraday chart for CytomX Therapeutics, Inc. -15.95% -11.61%
Jun. 17 CytomX Therapeutics, Inc. Promotes Chris Ogden to Chief Financial Officer CI
May. 28 Piper Sandler Upgrades CytomX Therapeutics to Overweight From Neutral, Adjusts Price Target to $3.50 From $2.25 MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. CTMX Stock
  4. Revisions CytomX Therapeutics, Inc.